Cargando…
Decreased levels of Fibroblast Growth Factor 21 are correlated with improved hypoglycemia in patients with insulinoma
Fibroblast growth factor-21 (FGF-21) improves insulin sensitivity and lipid metabolism in obese or diabetic animal models and has been proposed as a potential therapeutic agent for treating T2DM, obesity, and their related complications. However, little is known about the changes of FGF21 levels in...
Autores principales: | Li, Xu, Yu, Haoyong, Yin, Jun, Li, Lianxi, Zhou, Jian, Li, Ming, Li, Qing, Chen, Haibing, Liu, Fang, Bao, Yuqian, Han, Junfeng, Jia, Weiping |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5320496/ https://www.ncbi.nlm.nih.gov/pubmed/28225059 http://dx.doi.org/10.1038/srep43123 |
Ejemplares similares
-
The chloride/phosphate ratio combined with alkaline phosphatase as a valuable predictive marker for primary hyperparathyroidism in Chinese individuals
por: Wang, Qianqian, et al.
Publicado: (2017) -
Patterns of Circulating Fibroblast Growth Factor 21 in Subjects with and without Type 2 Diabetes
por: Lu, Jingyi, et al.
Publicado: (2015) -
Relationship between serum bilirubin concentrations and diabetic nephropathy in Shanghai Han’s patients with type 1 diabetes mellitus
por: Li, Xu, et al.
Publicado: (2017) -
Serum fibroblast growth factor 21 levels is associated with lower extremity atherosclerotic disease in Chinese female diabetic patients
por: Zhang, Xiaoyan, et al.
Publicado: (2015) -
Serum CA19-9 Level Associated with Metabolic Control and Pancreatic Beta Cell Function in Diabetic Patients
por: Yu, Haoyong, et al.
Publicado: (2012)